Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles.
Pozzorini C, Andre G, Coletta T, Buisson A, Bieler J, Ferrer L, Kempfer R, Saintigny P, Harlé A, Vacirca D, Barberis M, Gilson P, Roma C, Saitta A, Smith E, Consales Barras F, Ripol L, Fritzsche M, Marques AC, Alkodsi A, Marin R, Normanno N, Grimm C, Müllauer L, Harter P, Pignata S, Gonzalez-Martin A, Denison U, Fujiwara K, Vergote I, Colombo N, Willig A, Pujade-Lauraine E, Just PA, Ray-Coquard I, Xu Z. Pozzorini C, et al. Among authors: gilson p. Cell Rep Med. 2023 Dec 19;4(12):101344. doi: 10.1016/j.xcrm.2023.101344. Cell Rep Med. 2023. PMID: 38118421 Free PMC article.
Clinical Interest of Circulating Tumor DNA in Oncology.
Franczak C, Filhine-Tressarieu P, Broséus J, Gilson P, Merlin JL, Harlé A. Franczak C, et al. Among authors: gilson p. Arch Med Res. 2018 Jul;49(5):297-305. doi: 10.1016/j.arcmed.2018.10.007. Epub 2018 Nov 7. Arch Med Res. 2018. PMID: 30414710 Review.
Technical considerations for circulating tumor DNA detection in oncology.
Franczak C, Filhine-Tresarrieu P, Gilson P, Merlin JL, Au L, Harlé A. Franczak C, et al. Among authors: gilson p. Expert Rev Mol Diagn. 2019 Feb;19(2):121-135. doi: 10.1080/14737159.2019.1568873. Epub 2019 Jan 23. Expert Rev Mol Diagn. 2019. PMID: 30648442 Review.
Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.
Franczak C, Dubouis L, Gilson P, Husson M, Rouyer M, Demange J, Leroux A, Merlin JL, Harlé A. Franczak C, et al. Among authors: gilson p. PLoS One. 2019 Feb 27;14(2):e0212801. doi: 10.1371/journal.pone.0212801. eCollection 2019. PLoS One. 2019. PMID: 30811471 Free PMC article.
Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation.
Gilson P, Franczak C, Dubouis L, Husson M, Rouyer M, Demange J, Perceau M, Leroux A, Merlin JL, Harlé A. Gilson P, et al. PLoS One. 2019 Jul 2;14(7):e0219204. doi: 10.1371/journal.pone.0219204. eCollection 2019. PLoS One. 2019. PMID: 31265477 Free PMC article.
Emerging Roles of DDB2 in Cancer.
Gilson P, Drouot G, Witz A, Merlin JL, Becuwe P, Harlé A. Gilson P, et al. Int J Mol Sci. 2019 Oct 18;20(20):5168. doi: 10.3390/ijms20205168. Int J Mol Sci. 2019. PMID: 31635251 Free PMC article. Review.
Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.
Franczak C, Witz A, Geoffroy K, Demange J, Rouyer M, Husson M, Massard V, Gavoille C, Lambert A, Gilson P, Gambier N, Scala-Bertola J, Merlin JL, Harlé A. Franczak C, et al. Among authors: gilson p. PLoS One. 2020 Jan 15;15(1):e0227294. doi: 10.1371/journal.pone.0227294. eCollection 2020. PLoS One. 2020. PMID: 31940389 Free PMC article.
168 results